The role of primary care physicians in early diagnosis and treatment of chronic gastrointestinal diseases

International Journal of General Medicine

Volumn 7, Issue , 2014, Pages 159-173

  Gikas, Aristofanis ^a   Triantafillidis, John K ^b  

^a Health Center of Kalivia   (Greece)

^b IASO GENERAL HOSPITAL   (Greece)

Author keywords

Guidelines; Screening; Treatment

Indexed keywords

BULKING AGENT; CHLORDIAZEPOXIDE; CLIDINIUM BROMIDE; DIGESTIVE TRACT SPASMOLYTIC AGENT; ISPAGULA; LAXATIVE; MEBEVERINE; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; PROBIOTIC AGENT; PROKINETIC AGENT; PROTON PUMP INHIBITOR; RIFAXIMIN;

CANCER INCIDENCE; CANCER SCREENING; CELIAC DISEASE; CLINICAL COMPETENCE; CLINICAL PRACTICE; COLONOSCOPY; COLORECTAL CANCER; CONSTIPATION; CROHN DISEASE; DELAYED DIAGNOSIS; DIET THERAPY; DIETARY FIBER; DRUG INDICATION; DRUG USE; DUODENUM ULCER; DYSPEPSIA; EARLY DIAGNOSIS; ESOPHAGUS CANCER; EVIDENCE BASED MEDICINE; FECES INCONTINENCE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL DISEASE; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL SURGERY; GENERAL PRACTITIONER; HEALTH CARE QUALITY; HELICOBACTER INFECTION; HUMAN; INFLAMMATORY BOWEL DISEASE; IRRITABLE COLON; LIFESTYLE MODIFICATION; MEDICAL EDUCATION; OCCULT BLOOD TEST; PEPTIC ULCER; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PREVALENCE; PRIMARY MEDICAL CARE; PROFESSIONAL KNOWLEDGE; PROTOCOL COMPLIANCE; REVIEW; STOMACH CANCER; STOMACH PROTECTION; ULCERATIVE COLITIS;

EID: 84897868796     PISSN: None     EISSN: 11787074     Source Type: Book Series    
DOI: 10.2147/IJGM.S58888     Document Type: Review

References (114)

1. Peery AF, Dellon ES, Lund J, et al. Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterology. 2012;143:1179-1187.
2. Jones RH. Primary care research and clinical practice: gastroenterology. Postgrad Med J. 2008;84:454-458.
3. Flook NW. Management of gastrointestinal disease: Returning it to primary care. Can Fam Physician. 2004;50:685-686. [English, French].
4. Fletcher RH. Successful colorectal cancer screening starts with primary care. Rev Gastrointerol Disord. 2002;2 Suppl 1:S27-S34.
5. Seeff LC, Nadel MR, Klabunde CN, et al. Patterns and predictors of colorectal cancer test use in the adult US population. Cancer. 2004;100: 2093-2103.
6. Hanks H, Veitch C, Harris M. Colorectal cancer management - the role of the G P. Aust Fam Physician. 2008;37:259-261.
7. Schattner A, Gilad A. Primary care physicians' awareness and implementation of screening guidelines for colorectal cancer. Prev Med. 2002;35:447-452.
8. Xilomenos A, Mauri D, Kamposioras K, et al. Colorectal cancer screening awareness among physicians in Greece. BMC Gastroenterol. 2006;6:18.
9. Mauri D, Pentheroudakis G, Milousis A, et al. Colorectal cancer screening awareness in European primary care. Cancer Detect Prev. 2006;30:75-82.
10. Allemani C, Rachet B, Weir HK, et al. Colorectal cancer survival in the USA and Europe: a CONCORD high-resolution study. BMJ Open. 2013;3(9):e003055.
11. Cole SR, Young GP, Byrne D, Guy JR, Morsom J. Participation in screening for colorectal cancer based on fecal occult blood test is improved by endorsement by the primary care practitioner. J Med Screen. 2002;9:147-152.
12. Davis TC, Arnold CL, Rademaker AW, et al. FOBT completion in FQHCs: impact of physician recommendation, FOBT information, or receipt of the FOBT kit. J Rural Health. 2012;28:306-311.
13. Panzuto F, Chiriatti A, Bevilacqua S, et al. Symptom-based approach to colorectal cancer: survey of primary care physicians in Italy. Dig Liver Dis. 2003;35:869-875.
14. Astin M, Griffn T, Neal RD, Rose P, Hamilton W. The diagnostic value of symptoms for colorectal cancer in primary care: a systematic review. Br J Gen Pract. 2011;61:e231-e243.
15. Achkar E. Colorectal cancer screening in primary care: the long and short of it. Am J Gastroenterol. 2004;99:837-838.
16. Seeff LC, Richards TB, Shapiro JA, et al. How many endoscopies are performed for colorectal cancer screening? Results from CDC's survey of endoscopic capacity. Gastroenterology. 2004;127:1670-1677.
17. Edwards JK, Norris TE. Colonoscopy in rural communities: can family physicians perform the procedure with safe and effcacious results? J Am Board Fam Pract. 2004;17:353-358.
18. Wilkins T, LeClair B, Smolkin M, et al. Screening colonoscopies by primary care physicians: a meta-analysis. Ann Fam Med. 2009;7: 56-62.
19. Azzopardi J, DeWitt DE. Quality and safety issues in procedural rural practice: a prospective evaluation of current quality and safety guidelines in 3000 colonoscopies. Rural Remote Health. 2012;12:1949.
20. Kolber MR, Wong CK, Fedorak RN, Rowe BH; on behalf of the APC-Endo Study Physicians. Prospective Study of the Quality of Colonoscopies Performed by Primary Care Physicians: The Alberta Primary Care Endoscopy (APC-Endo) Study. PLoS One. 2013;8:e67017.
21. Yuan Y. A survey and evaluation of population-based screening for gastric cancer. Cancer Biol Med. 2013;10:72-80.
22. Asaka M, Kato M, Graham DY. Strategy for eliminating gastric cancer in Japan. Helicobacter. 2010;15:486-490.
23. Dan YY, So JB, Yeoh KG. Endoscopic screening for gastric cancer. Clin Gastroenterol Hepatol. 2006;4:709-716.
24. Ryan J, Murkies A. Diagnosis of upper gastrointestinal malignancy. Aust Fam Physician. 2006;35:200-201.
25. Maconi G, Manes G, Porro GB. Role of symptoms in diagnosis and outcome of gastric cancer. World J Gastroenterol. 2008;14:1149-1155.
26. Goddard AF, James MW, McIntyre AS, Scott BB; British Society of Gastroenterology. Guidelines for the management of iron defciency anaemia. Gut. 2011;60:1309-1316.
27. Logan EC, Yates JM, Stewart RM, Fielding K, Kendrick D. Investigation and management of iron defciency anaemia in general practice: a cluster randomized controlled trial of a simple management prompt. Postgrad Med J. 2002;78:533-537.
28. Droogendijk J, Beukers R, Berendes PB, Tax MG, Sonneveld P, Levin MD. Screening for gastrointestinal malignancy in patients with iron defciency anemia by general practitioners: an observational study. Scand J Gastroenterol. 2011;46:1105-1110.
29. Bramble MG, Suvacovic Z, Hungin AP. Detection of upper gastrointestinal cancer in patients taking antisecretory therapy prior to gastroscopy. Gut. 2000;46:464-467.
30. Panter SJ, O'Flanagan H, Bramble MG, Hungin AP. Empirical use of antisecretory drug therapy delays diagnosis of upper gastrointestinal adenocarcinoma but does not effect outcome. Aliment Pharmacol Ther. 2004;19:981-988.
31. Wayman J, Hayes N, Raimes SA, Griffn SM. Prescription of proton pump inhibitors before endoscopy. A potential cause of missed diagnosis of early gastric cancers. Arch Fam Med. 2000;9:385-388.
32. Voutilaimen M, Kunnamo I. A survey of open-access endoscopy in primary health care centers: outcome of gastric carcinoma patients diagnosed by general practitioners compared with hospital-referred endoscopy. Dig Liver Dis. 2005;37:119-123.
33. Lagergren J, Lagergren P. Oesophageal cancer. BMJ. 2010;341:c6280.
34. Witzig R, Schönberger B, Fink U, et al. Delays in diagnosis and therapy of gastric cancer and esophageal adenocarcinoma. Endoscopy. 2006;38:1122-1126.
35. Subasinghe D, Samarasekera DN. Delay in the diagnosis of esophageal carcinoma: experience of a single unit from a developing country. Indian J Cancer. 2010;47:151-155.
36. Hippisley-Cox J, Coupland C. Identifying patients with suspected gastro-oesophageal cancer in primary care: derivation and validation of an algorithm. Br J Gen Pract. 2011;61:e707-e714.
37. Collins GS, Altman DG. Identifying patients with undetected gastro-oesophageal cancer in primary care: External validation of QCancer® (Gastro-Oesophageal). Eur J Cancer. 2013;49:1040-1048.
38. Fitzgerald RC, Di Pietro M, Ragunath K, et al. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus. Gut. 2014;63:7-42.
39. Ford AC, Moayyedi P. Dyspepsia. BMJ. 2013;347:29-33.
40. Hungin AP, Rubin GP. Management of dyspepsia across the primary-secondary healthcare interface. Dig Dis. 2001;19:219-224.
41. Ford AC, Marwaha A, Lim A, Moayyedi P. What is the prevalence of clinically signifcant endoscopic fndings in subjects with dyspepsia? Systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2010;8:830-837.
42. Malfertheiner P, Megraud F, O'Morain CA, et al. The European Helicobacter Study Group (EHSG). Management of Helicobacter pylori infection - the Maastricht IV/Florence consensus report. Gut. 2012;61(5):646-664.
43. Vakil N. Dyspepsia, peptic ulcer, and H. pylori: a remembrance of things past. Am J Gastroenterol. 2010;105:572-574.
44. Wee EW. Evidence-based approach to dyspepsia: from Helicobacter pylori to functional disease. Postgrad Med. 2013;125:169-180.
45. Talley NJ. Modern management of dyspepsia. Aust Fam Physician. 1996;25:47-52.
46. No authors listed. Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter Pylori Study Group. Gut. 1997;41: 8-13.
47. Bennett K, Feely J, Thornton O, Dobson M, O'Morain CA, O'Connor HJ. Impact of Helicobacter pylori on the management of dyspepsia in primary care. Aliment Pharmacol Ther. 2006;24:637-641.
48. Kim BG, Kim JW, Jeong JB, et al. Discrepancies between primary physician practice and treatment guidelines for Helicobacter pylori infection in Korea. World J Gastroenterol. 2006;12:66-69.
49. Ahmed S, Salih M, Jafri W, Ali Shah H, Hamid S. Helicobacter pylori infection: approach of primary care physicians in a developing country. BMC Gastroenterol. 2009;9:23.
50. Seifert B, Rubin G, De Wit N, et al. The management of common gastrointestinal disorders in general practice A survey by the European Society for Primary Care Gastroenterology (ESPCG) in six European countries. Dig Liver Dis. 2008;40:659-666.
51. O'Connor HJ. Helicobacter pylori and dyspepsia: physicians' attitudes, clinical practice, and prescribing habits. Aliment Pharmacol Ther. 2002;16:487-496.
52. Hirth RA, Fendrick AM, Chernew ME. Specialist and generalist physicians' adoption of antibiotic therapy to eradicate Helicobacter pylori infection. Med Care. 1996;34:1199-1204.
53. Spiegel BM, Farid M, van Oijen MG, Laine L, Howden CW, Esrailian E. Adherence to best practice guidelines in dyspepsia: a survey comparing dyspepsia experts, community gastroenterologists and primary-care providers. Aliment Pharmacol Ther. 2009;29(8):871-881.
54. Chubineh S, Birk J. Proton pump inhibitors: the good, the bad, and the unwanted. South Med J. 2012;105:613-618.
55. Naunton M, Peterson GM, Bleasel MD. Overuse of proton pump inhibitors. J Clin Pharm Ther. 2000;25:333-340.
56. Batuwitage BT, Kingham JG, Morgan NE, Bartlett RL. Inappropriate prescribing of proton pump inhibitors in primary care. Postgrad Med J. 2007;83:66-68.
57. Heidelbaugh JJ, Kim AH, Chang R, Walker PC. Overutilization of proton-pump inhibitors: what the clinician needs to know. Therap Adv Gastroenterol. 2012;5:219-232.
58. Patterson Burdsall D, Flores HC, Krueger J, et al. Use of proton pump inhibitors with lack of diagnostic indications in 22 Midwestern US skilled nursing facilities. J Am Med Dir Assoc. 2013;14:429-432.
59. Rostom A, Moayyedi P, Hunt R; Canadian Association of Gastroenterology Consensus Group. Canadian consensus guidelines on long-term nonsteroidal anti-infammatory drug therapy and the need for gastroprotection: benefts versus risks. Aliment Pharmacol Ther. 2009;29:481-496.
60. Morini S, Zullo A, Oliveti D, et al. A very high rate of inappropriate use of gastroprotection for nonsteroidal anti-infammatory drug therapy in primary care: a cross-sectional study. J Clin Gastroenterol. 2011;45: 780-784.
61. Zullo A, Hassan C, Oliveti D, et al. Helicobacter pylori management in non-steroidal anti-infammatory drug therapy patients in primary care. Intern Emerg Med. 2012;7:331-335.
62. Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal refux disease. Am J Gastroenterol. 2013;108:308-328.
63. Ornstein SM, Nietert PJ, Jenkins RG, Litvin CB. The prevalence of chronic diseases and multimorbidity in primary care practice: a PPRNet report. J Am Board Fam Med. 2013;26:518-524.
64. DeVault KR, Castell DO. Guidelines for the diagnosis and treatment of gastroesophageal refux disease. Practice Parameters Committee of the American College of Gastroenterology. Arch Intern Med. 1995;15:2165-2173.
65. Jones R, Liker HR, Ducrotté P. Relationship between symptoms, subjective well-being and medication use in gastro-oesophageal refux disease. Int J Clin Pract. 2007;61:1301-1307.
66. Gisbert JP, Cooper A, Karagiannis D, et al. Management of gastro-oesophageal refux disease in primary care: a European observational study. Curr Med Res Opin. 2009;25:2777-2784.
67. Wilcox CM, Heudebert G, Klapow J, Shewchuk R, Casebeer L. Survey of primary care physicians' approach to gastroesophageal refux disease in elderly patients. J Gerontol A Biol Sci Med Sci. 2001;56:M514-M517.
68. Wong WM, Lim P, Wong BC. Clinical practice pattern of gastroenterologists, primary care physicians, and otolaryngologists for the management of GERD in the Asia Pacifc region: the FAST survey. J Gastroenterol Hepatol. 2004;19:S54-S60.
69. Bretagne JF, Honnorat C, Richard-Molard B, Souffet C, Barthélemy P. Perceptions and practices on the management of gastro-oesophageal reflux disease: results of a national survey comparing primary care physicians and gastroenterologists. Aliment Pharmacol Ther. 2007;25:823-833.
70. Halpern R, Kothari S, Fuldeore M, et al. GERD-related health care utilization, therapy, and reasons for transfer of GERD patients between primary care providers and gastroenterologists in a US managed care setting. Dig Dis Sci. 2010;55:328-337.
71. Fallone CA, Guyatt GH, Armstrong D, et al. Do physicians correctly assess patient symptom severity in gastro-oesophageal refux disease? Aliment Pharmacol Ther. 2004;20:1161-1169.
72. McColl E, Junghard O, Wiklund I, Revicki DA. Assessing symptoms in gastroesophageal reflux disease: how well do clinicians' assessments agree with those of their patients? Am J Gastroenterol. 2005;100:11-18.
73. Flook NW, Wiklund I. Accounting for the effect of GERD symptoms on patients' health-related quality of life: supporting optimal disease management by primary care physicians. Int J Clin Pract. 2007;61:2071-2078.
74. Ponce J, Garrigues V, Agréus L, et al. Structured management strategy based on the Gastro-oesophageal Refux Disease (GERD) Questionnaire (GerdQ) vs usual primary care for GERD: pooled analysis of fve cluster-randomised European studies. Int J Clin Pract. 2012;66:897-905.
75. De Boer AG, Sprangers MA, Bartelsman JF, de Haes HC. Predictors of health care utilization in patients with infammatory bowel disease: a longitudinal study. Eur J Gastroenterol Hepatol. 1998;10:783-789.
76. Knutson D, Greenberg G, Cronau H. Management of Crohn's disease - a practical approach. Am Fam Physician. 2003;68:707-714.
77. Gikas A. IBD and Primary Care Physician. In: Triantafllidis JK, Stanciu C, editors. Inflammatory Bowel Disease: Pathogenesis, Clinical Manifestations, Diagnosis, Treatment. Athens: Technogramma Publications; 2012:659-666.
78. Stotland BR, Stein RB, Lichtenstein GR. Advances in infammatory bowel disease. Med Clin North Am. 2000;84:1107-1124.
79. Morrison G, Headon B, Gibson P. Update in infammatory bowel disease. Aust Fam Physician. 2009;38:956-961.
80. Casellas F, Fontanet G, Borruel N, Malagelada JR. The opinion of patients with infammatory bowel disease on healthcare received. Rev Esp Enferm Dig. 2004;96:174-184.
81. Hilsden RJ, Verhoef MJ, Best A, Pocobelli G. A national survey on the patterns of treatment of infammatory bowel disease in Canada. BMC Gastroenterol. 2003;3:10.
82. Sossai P, Filippetti F, Muselmani AA, Catalini G. Inflammatory bowel diseases and the general practitioner's role in a region of Central Italy. Clin Exp Gastroenterol. 2010;3:27-31.
83. Williams JG, Cheung WY, Russell IT, Cohen DR, Longo M, Lervy B. Open access follow up for inflammatory bowel disease: pragmatic randomised trial and cost effectiveness study. BMJ. 2000;320(7234):544-548.
84. Husain A, Triadaflopoulos G. Communicating with patients with inflammatory bowel disease. Infamm Bowel Dis. 2004;10:444-450.
85. Triantafllidis JK, Merikas E, Gikas A. Psychological factors and stress in inflammatory bowel disease. Expert Rev Gastroenterol Hepatol. 2013;7:225-238.
86. McFarland LV. State-of-the-art of irritable bowel syndrome and inflammatory bowel disease research in 2008. World J Gastroenterol. 2008;14:2625-2629.
87. Spiller R, Aziz Q, Creed F, Emmanuel A, Houghton L, Hungin P. Guidelines for the management of irritable bowel syndrome. Gut. 2007;56:1770-1798.
88. Irritable bowel syndrome in adults [webpage on the Internet]. National Institute for Health and Clinical Excellence; 2008. Available from: http://www.nice.org.uk/CG061. Accessed October 11, 2013.
89. Spiegel BM. Do physicians follow evidence-based guidelines in the diagnostic work-up of IBS? Nat Clin Pract Gastroenterol Hepatol. 2007;4:296-297.
90. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology. 2006;130(5): 1480-1491.
91. Spiegel BM, Farid M, Esrailian E, Talley J, Chang L. Is irritable bowel syndrome a diagnosis of exclusion?: a survey of primary care providers, gastroenterologists, and IBS experts. Am J Gastroenterol. 2010;105: 848-858.
92. Gladman LM, Gorard DA. General practitioner and hospital specialist attitudes to functional gastrointestinal disorders. Aliment Pharmacol Ther. 2003;17:651-654.
93. Olafsdottir LB, Gudjonsson H, Jonsdottir HH, Jonsson JS, Bjornsson E, Thjodleifsson B. Irritable bowel syndrome: physicians' awareness and patients' experience. World J Gastroenterol. 2012;18:3715-3720.
94. Saadi M, McCallum RW. Rifaximin in irritable bowel syndrome: rationale, evidence and clinical use. Ther Adv Chronic Dis. 2013;4: 71-75.
95. McKenzie YA, Alder A, Anderson W, et al; Gastroenterology Specialist Group of the British Dietetic Association. British Dietetic Association evidence-based guidelines for the dietary management of irritable bowel syndrome in adults. J Hum Nutr Diet. 2012;25:260-274.
96. Hungin AP, Mulligan C, Pot B, et al. Systematic review: probiotics in the management of lower gastrointestinal symptoms in clinical practice - an evidence-based international guide. Aliment Pharmacol Ther. 2013;38:864-886.
97. Di Palma JA, Herrera JL. The role of effective clinician-patient communication in the management of irritable bowel syndrome and chronic constipation. J Clin Gastroenterol. 2012;46:748-751.
98. Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology. 2006;130:1377-1390.
99. Michael M. Recognizing and managing celiac disease in primary care. J Am Acad Nurse Pract. 2003;15:108-114.
100. Khangura J, Van den Bruel A, Perera R, et al. Point-of-care testing for coeliac disease: primary care diagnostic technology update. Br J Gen Pract. 2013;63:e426-e428.
101. American Gastroenterological Association, Bharucha AE, Dorn SD, Lembo A, Pressman A. American Gastroenterological Association medical position statement on constipation. Gastroenterology. 2013;144:211-217.
102. Shahid S, Ramzan Z, Maurer AH, Parkman HP, Fisher RS. Chronic idiopathic constipation: more than a simple colonic transit disorder. J Clin Gastroenterol. 2012;46:150-154.
103. Pare P. The approach to diagnosis and treatment of chronic constipation: suggestions for a general practitioner. Can J Gastroenterol. 2011; 25 Suppl B:36B-40B.
104. Costilla VC, Foxx-Orenstein AE, Mayer AP, Crowell MD. Office-based management of fecal incontinence. Gastroenterol Hepatol (N Y). 2013;9:423-433.
105. Dunivan GC, Heymen S, Palsson OS, et al. Fecal incontinence in primary care: prevalence, diagnosis, and health care utilization. Am J Obstet Gynecol. 2010;202:493. e1-e6.
106. Harrold LR, Field TS, Gurwitz JH. Knowledge, patterns of care, and outcomes of care for generalists and specialists. J Gen Intern Med. 1999;14:499-511.
107. Ferrante JM, Lee JH, McCarthy EP, et al. Primary care utilization and colorectal cancer incidence and mortality among medicare benefciaries: a population-based, case-control study. Ann Intern Med. 2013;159:437-446.
108. Hudson SV, Ohman-Strickland P, Cunningham R, Ferrante JM, Hahn K, Crabtree BF. The effects of teamwork and system support on colorec-tal cancer screening in primary care practices. Cancer Detect Prev. 2007;31:417-423.
109. Atassi K. Strategies to increase colorectal cancer screening. Nurse Pract. 2012;37:21-26.
110. Lacy BE, Weiser K, De Lee R. The treatment of irritable bowel syndrome. Therap Adv Gastroenterol. 2009;2:221-238.
111. Graham ID, Harrison MB. Evaluation and adaptation of clinical practice guidelines. Evid Based Nurs. 2005;8:68-72.
112. Schichtel M, Rose PW, Sellers C. Educational interventions for primary healthcare professionals to promote the early diagnosis of cancer: a systematic review. Educ Prim Care. 2013;24:274-290.
113. Longstreth GF, Burchette RJ. Family practitioners' attitudes and knowledge about irritable bowel syndrome: effect of a trial of physician education. Fam Pract. 2003;20:670-674.
114. Davis DA, Taylor-Vaisey A. Translating guidelines into practice. A systematic review of theoretic concepts, practical experience and research evidence in the adoption of clinical practice guidelines. CMAJ. 1997;157:408-416.